Navigation path

Pharmaceuticals - Community Register


Community register of medicinal products for human use


Product information

Invented name: Levetiracetam ratiopharm   
Auth. number : EU/1/11/702
INN : levetiracetam
ATC: Anatomical main group: N - Nervous system
Therapeutic subgroup: N03 - Antiepileptics
Pharmacological subgroup: N03A - Antiepileptics
Chemical subgroup: N03AX - Other antiepileptics
Chemical substance: N03AX14 - Levetiracetam
(See WHO ATC Index)
Indication: Indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Marketing Authorisation Holder: ratiopharm GmbH
Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2011 Centralised - Authorisation EMEA/H/C/2244 (2011)6239 of 26/08/2011
02/02/2012 Centralised - Variation EMEA/H/C/2244/IB/4
Updated with Decision(2012)6389 of 10/09/2012
10/08/2012 Centralised - Variation EMEA/H/C/2244/IB/5
Updated with Decision(2012)6389 of 10/09/2012
12/09/2012 Centralised - Variation (2012)6389 of 10/09/2012
10/12/2013 Centralised - Variation EMEA/H/C/2244/IB/8
24/04/2014 Centralised - Variation EMEA/H/C/2244/IB/9